Kamada confirms it’s mulling Wall Street offering

The drug development company says no decision has been made on the terms of a possible offering.

Wall Street_311 (photo credit: Thinkstock/Imagebank)
Wall Street_311
(photo credit: Thinkstock/Imagebank)


Tags Market